Avatrombopag for the salvage treatment of platelet transfusion refractoriness.
Yuehong QinYu WangYujiao ZhangYingying JiaoJieyu YePublished in: Therapeutic advances in hematology (2024)
Our study suggests that avatrombopag is an effective and safe treatment option for refractory PTR patients.